The Barrier Breaking Down

Time To Read

1–2 minutes

Date Last Modified

5

CHART CLUE

Across a lifetime, Stina collected five “separate” skin diagnoses — guttate psoriasis, eczema, a sterile “fever rash,” mottled red legs, and slow-healing wounds. Each was treated as a local dermatology problem. Read together, they are one systemic, IL-1β/IL-6-driven autoinflammatory disease wearing the skin as its billboard.

The summer she turned 35, Stina’s psoriasis quietly stepped back. She barely had time to celebrate. Within months, dry, cracked, weeping eczema spread across her hands and inner elbows, and a scatter of tender, pus-topped bumps appeared on her arms during a feverish week. Three clinicians gave three labels and three creams. No one stood back to ask why one woman’s skin was failing in three ways at once.

These look like opposite problems, and at the cellular level they are. Psoriasis is a speed problem — keratinocytes race to the surface. Eczema is a quality problem — the barrier lipids and tight junctions that seal the stratum corneum break down, so water escapes and irritants pour in. The pustules are a third thing: sterile pus, neutrophils stacking up with no germ to fight. One signal can produce all three, because IL-1β can whip the conveyor belt, degrade the barrier, and recruit neutrophils at the same time. Stina’s skin wasn’t confused; it was being driven by a single upstream switch.

From Stina’s chart: Age 35: psoriasis remission noted — and the same year, new-onset eczema and a crop of tender pustules. Three diagnoses, three referrals, zero connections.

Those feverish pustules weren’t an infection the swabs missed. They were a named condition — one whose very definition is “neutrophils, no organisms.” Meet Stina’s fever rash.

PREVIOUS

The Rash Nobody Noticed

NEXT

The Fever Rash

List of terms